The excerpt the platform analyzed
“The Edison platform is capable of performing over 200 standard laboratory tests from a single drop of blood drawn from a fingertip. Our proprietary micro-sample technology eliminates the need for traditional venipuncture, making diagnostic testing faster, cheaper, and accessible to millions. We project deployment across 10,000 pharmacy locations within 24 months.”
4 red flags in the document
Each flag below was detectable from the document text alone. No outcome data. No hindsight.
4 biases across the document
Questions the steering committee would ask
Predicted from the document's own signals. In the live product, these are generated from your memo — no two runs produce the same list.
What a bias-adjusted process would have done
Board requires peer-reviewed validation of Edison technology as a condition of any partnership; Walgreens insists on independent third-party testing before rolling out to stores; early-stage investors (Draper, Oracle's Ellison, DeVos family) condition investment on technical due diligence from a diagnostics-specialist firm; board refreshes to include at least two diagnostics or molecular biology experts alongside political figures.
Theranos is the modern canonical halo-effect/authority-bias failure. Every due-diligence failure traces to the same structural problem: prestigious board, zero domain expertise. The decision to waive technical validation in the presence of "Kissinger and Shultz" is the bias.
What was visible, and when
Every event below was documentable before the outcome was known. The platform looks for signals like these in live memos.
- 2003Holmes drops out of Stanford and founds Real-Time Cures (later Theranos) at age 19.John Carreyrou, "Bad Blood" (2018)
- 2013-09Walgreens begins rollout of Theranos "wellness centers" in Arizona and California stores.Walgreens–Theranos partnership announcement
- 2014-06Forbes cover story pegs Holmes's net worth at $4.5B based on $9B Theranos valuation.Forbes, June 2014
- 2015-02Internal whistleblower Tyler Shultz (grandson of board member George Shultz) files concerns with NY State Department of Health.Tyler Shultz testimony, U.S. v. Holmes
- 2015-10-15John Carreyrou publishes WSJ investigation: Theranos running most tests on third-party Siemens machines, not Edison.Wall Street Journal, October 15 2015
- 2016-01CMS inspection finds deficiencies "jeopardize patient health and safety" at Theranos Newark lab.CMS Form 2567 inspection report
- 2018-03-14SEC charges Theranos, Holmes, and former COO Balwani with "massive fraud."SEC v. Theranos, Case 5:18-cv-01602
- 2022-01-03Jury convicts Holmes on 4 counts of investor fraud.U.S. v. Holmes, N.D. Cal.
- 2022-11-18Holmes sentenced to 135 months in federal prison.U.S. v. Holmes, sentencing order
Stakeholders and positions
Who advocated, who dissented, who was overruled, and who stayed silent — the most reliable single signal of decision-process quality.
Other decisions with the same pattern
Run your own strategic memo in 60 seconds.
Same bias framework, same pre-decision evidence discipline. Upload a strategic memo or board deck — get the DQI grade, flagged biases, predicted questions, and counterfactual back before your next meeting.